Chimerix Inc CMRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:04 PM EDT
1.05quote price arrow up+0.04 (+3.97%)
Volume
205,234
52 week range
0.88 - 1.57
Loading...
  • Open1.03
  • Day High1.06
  • Day Low1.00
  • Prev Close1.01
  • 52 Week High1.57
  • 52 Week High Date06/07/23
  • 52 Week Low0.88
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap93.68M
  • Shares Out89.21M
  • 10 Day Average Volume0.57M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change9.61

KEY STATS

  • Open1.03
  • Day High1.06
  • Day Low1.00
  • Prev Close1.01
  • 52 Week High1.57
  • 52 Week High Date06/07/23
  • 52 Week Low0.88
  • 52 Week Low Date11/10/23
  • Market Cap93.68M
  • Shares Out89.21M
  • 10 Day Average Volume0.57M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change9.61

RATIOS/PROFITABILITY

  • EPS (TTM)-0.93
  • P/E (TTM)-1.13
  • Fwd P/E (NTM)-1.14
  • EBITDA (TTM)-92.974M
  • ROE (TTM)-36.50%
  • Revenue (TTM)324,000.001
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-25,337.96%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Chimerix Inc

 

Profile

MORE
Chimerix, Inc. is a biotechnology company. The Company is focused on developing medicines that address unmet medical needs. The Company's product Imipridones is a cancer therapy that provides ONC201, which is in clinical-stage development for H3 K27M-mutant glioma as its lead indication. In addition, imipridone ONC206 is in dose-escalating clinical trials. Imipridones target specific G protein-coupled receptors (GPCRs) and mitochondrial caseinolytic protease P (ClpP)...
Michael Sherman
Chairman of the Board
Michael Andriole
President, Chief Executive Officer, Director
Thomas Riga
Chief Operating Officer, Chief Commercial Officer
Michelle LaSpaluto
Chief Financial Officer
Address
2505 Meridian Parkway, Suite 100
Durham, NC
27713
United States

Top Peers

SYMBOLLASTCHG%CHG
IFRX
InflaRx NV
1.53-0.01-0.65%
CRVS
Corvus Pharmaceuticals Inc
1.81+0.02+1.12%
JSPR
Jasper Therapeutics Inc
29.82+1.00+3.48%
PMVP
PMV Pharmaceuticals Inc
1.69+0.04+2.12%
ALVR
Allovir Inc
0.7598-0.0017-0.2232%